Patents by Inventor Scott M. Gordon

Scott M. Gordon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11872261
    Abstract: Described herein is the design and construction of a class of lipoprotein targeting protease inhibitors. Small peptides with protease inhibitor activity are conjugated to hydrophobic, lipoprotein targeting molecules using, for instance, amine reactive chemistry. Methods of use of the resultant lipoprotein targeting protease inhibitor (antiprotease) molecules are also described. Also described is the production and use of protease inhibitor enriched HDL particles, as well as A1AT-peptide-enriched HDL particles, and their use in various therapeutic contexts.
    Type: Grant
    Filed: February 16, 2022
    Date of Patent: January 16, 2024
    Assignee: The United States of America, as represented by the Secretary, Department of Health and Human Services
    Inventors: Alan T. Remaley, Scott M. Gordon
  • Publication number: 20230201298
    Abstract: Described herein is the design and construction of a class of lipoprotein targeting protease inhibitors. Small peptides with protease inhibitor activity are conjugated to hydrophobic, lipoprotein targeting molecules using, for instance, amine reactive chemistry. Methods of use of the resultant lipoprotein targeting protease inhibitor (antiprotease) molecules are also described. Also described is the production and use of protease inhibitor enriched HDL particles, as well as AlAT-peptide-enriched HDL particles, and their use in various therapeutic contexts.
    Type: Application
    Filed: June 13, 2022
    Publication date: June 29, 2023
    Applicant: The United States of America, as represented by the Secretary, Dept. of Health and Human Services
    Inventors: Alan T. Remaley, Scott M. Gordon
  • Publication number: 20220168379
    Abstract: Described herein is the design and construction of a class of lipoprotein targeting protease inhibitors. Small peptides with protease inhibitor activity are conjugated to hydrophobic, lipoprotein targeting molecules using, for instance, amine reactive chemistry. Methods of use of the resultant lipoprotein targeting protease inhibitor (antiprotease) molecules are also described. Also described is the production and use of protease inhibitor enriched HDL particles, as well as A1AT-peptide-enriched HDL particles, and their use in various therapeutic contexts.
    Type: Application
    Filed: February 16, 2022
    Publication date: June 2, 2022
    Applicant: The United States of America, as represented by the Secretary, Dept. of Health and Human Services
    Inventors: Alan T. Remaley, Scott M. Gordon
  • Patent number: 11061047
    Abstract: A sensor for measuring displacement and time comprises a hollow body including a longitudinal axis. The hollow body comprises a wall including an inner surface and an outer surface, and a pathway defined by the inner surface. The sensor further comprises a solid body including an outer surface, the solid body configured to be received by the hollow body and travel through the pathway. The sensor further comprises a plurality of frangible wires, where each wire of the plurality of wires extends through a first opening in the wall, across the pathway, and through a second opening in the wall, and each wire is spaced apart by a distance in a direction generally parallel to the longitudinal axis of the hollow body.
    Type: Grant
    Filed: March 28, 2019
    Date of Patent: July 13, 2021
    Assignee: TOYOTA MOTOR ENGINEERING & MANUFACTURING NORTH AMERICA, INC.
    Inventors: Skylar C. Watson, Scott M. Gordon, Zachary T. Pawson
  • Publication number: 20200309807
    Abstract: A sensor for measuring displacement and time comprises a hollow body including a longitudinal axis. The hollow body comprises a wall including an inner surface and an outer surface, and a pathway defined by the inner surface. The sensor further comprises a solid body including an outer surface, the solid body configured to be received by the hollow body and travel through the pathway. The sensor further comprises a plurality of frangible wires, where each wire of the plurality of wires extends through a first opening in the wall, across the pathway, and through a second opening in the wall, and each wire is spaced apart by a distance in a direction generally parallel to the longitudinal axis of the hollow body.
    Type: Application
    Filed: March 28, 2019
    Publication date: October 1, 2020
    Inventors: Skylar C. Watson, Scott M. Gordon, Zachary T. Pawson
  • Publication number: 20200078434
    Abstract: Described herein is the design and construction of a class of lipoprotein targeting protease inhibitors. Small peptides with protease inhibitor activity are conjugated to hydrophobic, lipoprotein targeting molecules using, for instance, amine reactive chemistry. Methods of use of the resultant lipoprotein targeting protease inhibitor (antiprotease) molecules are also described. Also described is the production and use of protease inhibitor enriched HDL particles, as well as A1AT-peptide-enriched HDL particles, and their use in various therapeutic contexts.
    Type: Application
    Filed: November 22, 2019
    Publication date: March 12, 2020
    Applicant: The United States of America, as represented by the Secretary, Dept. of Health and Human Services
    Inventors: Alan T. Remaley, Scott M. Gordon
  • Patent number: 10422722
    Abstract: A modular cart for use with an anthropomorphic test device, an assembly including an anthropomorphic test device and a method of placing an anthropomorphic test device on a modular cart. The cart includes a wheeled base with a pair of upstanding posts that together with members that can be interchangeably secured to one of the posts in order to form one of a storage position or a ready-to-test position. In this way, when an anthropomorphic test device is placed on the cart between these members, the members and the posts cooperate with one another to have the anthropomorphic test device be in a generally seating position that can accommodate both storage and testing without having to reposition the anthropomorphic test device.
    Type: Grant
    Filed: December 19, 2016
    Date of Patent: September 24, 2019
    Assignee: Toyota Motor Engineering & Manufacturing North America, Inc.
    Inventors: Jared P. Vogt, Scott M. Gordon
  • Publication number: 20180170416
    Abstract: A modular cart for use with an anthropomorphic test device, an assembly including an anthropomorphic test device and a method of placing an anthropomorphic test device on a modular cart. The cart includes a wheeled base with a pair of upstanding posts that together with members that can be interchangeably secured to one of the posts in order to form one of a storage position or a ready-to-test position. In this way, when an anthropomorphic test device is placed on the cart between these members, the members and the posts cooperate with one another to have the anthropomorphic test device be in a generally seating position that can accommodate both storage and testing without having to reposition the anthropomorphic test device.
    Type: Application
    Filed: December 19, 2016
    Publication date: June 21, 2018
    Applicant: Toyota Motor Engineering & Manufacturing North America, Inc.
    Inventors: Jared P. Vogt, Scott M. Gordon
  • Publication number: 20170319643
    Abstract: Described herein is the design and construction of a class of lipoprotein targeting protease inhibitors. Small peptides with protease inhibitor activity are conjugated to hydrophobic, lipoprotein targeting molecules using, for instance, amine reactive chemistry. Methods of use of the resultant lipoprotein targeting protease inhibitor (antiprotease) molecules are also described. Also described is the production and use of protease inhibitor enriched HDL particles, as well as A1AT-peptide-enriched HDL particles, and their use in various therapeutic contexts.
    Type: Application
    Filed: October 18, 2016
    Publication date: November 9, 2017
    Applicant: The United States of America, as represented by the Secretary, Department of Health and Human Serv
    Inventors: Alan T. Remaley, Scott M. Gordon